New IPF drug ENV-101 tested with standard meds in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study looks at how the experimental drug ENV-101 interacts with two standard IPF medicines, nintedanib and pirfenidone, in healthy adults. Researchers will measure drug levels in the blood to understand safety and dosing. The study involves 57 participants across…
Phase: PHASE1 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC